| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Branding > Build and Manage Successful Brands with BIOs (Brand Impression Opportunities) |
|
Digg It - Build and Manage Successful Brands with BIOs (Brand Impression Opportunities)
What a fascinating time we live in; hundreds of new products enter the marketplace every day. More books are published ea According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ch year than used to be published in entire decades. We have access to a seemingly endless availability of news, televisi ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in n and radio stations, communication devices, and information. This onslaught leaves marketers with what some see as an a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. most insurmountable task -- developing effective ways to break through the deluge of information and have their messages here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe esonate with their target audiences. I, however, see this as an incredible opportunity. Since accomplishing this feat has d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro become more difficult over the years, many companies do not bother to market as required by today's environment, or wors ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc yet, they do not market at all. What better opportunity could a progressively-minded company ask for? With this tremend easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi us opportunity comes a massive responsibility. When a company's message gets through the clutter and rings true in the ta nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically get audience's ear, the company must not only uphold its promise at every contact it has with its customers, but it must and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ also surpass that promise -- every time, by every employee, by every product, by every system. Indeed, if a positive bran ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi impression is not made at every contact, the odds of the company's message effectively getting through to that prospect ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a gain are greatly diminished, and what was an advantage becomes a more-difficult-than-ever undertaking. Give thought to e dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod ery way you and your company come into contact with your prospects and customers. Do you wow them, or are you just like e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin veryone one else? Think about the Brand Impression Opportunities (BIOs) that you have, the ones you can create, and how y tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen u can turn them from mere possibilities into positive interactions -- interactions that reverberate with your customers . t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel . interactions that are memorable experiences ... interactions that make such an impression that your customers willingly ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust and spontaneously tell others about you. In today's hectic world, this is essential. No matter how good your product is, y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products no matter what the benefits are, unless your customers have unusually great experiences with your product, employees, and . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de systems each and every time they interact with them, your sales and profits suffer. Let your competitors offer an everyda elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip experience. Stand above the rest and have prospects become customers, and customers become your greatest brand champions tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Power of Many - Online Consumer Help Resources Vending Machine Business-How To Start One Medical Billing - Many Players, Many Problems
|